676 related articles for article (PubMed ID: 34446045)
1. SLC7A11 regulated by NRF2 modulates esophageal squamous cell carcinoma radiosensitivity by inhibiting ferroptosis.
Feng L; Zhao K; Sun L; Yin X; Zhang J; Liu C; Li B
J Transl Med; 2021 Aug; 19(1):367. PubMed ID: 34446045
[TBL] [Abstract][Full Text] [Related]
2. Nuclear factor erythroid 2-related factor 2 promotes radioresistance by regulating glutamate-cysteine ligase modifier subunit and its unique immunoinvasive pattern.
Xue Z; Nuerrula Y; Sitiwaerdi Y; Eli M
Biomol Biomed; 2024 May; 24(3):545-559. PubMed ID: 38340316
[TBL] [Abstract][Full Text] [Related]
3. The expression of p-p62 and nuclear Nrf2 in esophageal squamous cell carcinoma and association with radioresistance.
Wang Z; Zhang J; Li M; Kong L; Yu J
Thorac Cancer; 2020 Jan; 11(1):130-139. PubMed ID: 31755241
[TBL] [Abstract][Full Text] [Related]
4. EZH2-mediated SLC7A11 upregulation via miR-125b-5p represses ferroptosis of TSCC.
Yu Y; MohamedAl-Sharani H; Zhang B
Oral Dis; 2023 Apr; 29(3):880-891. PubMed ID: 34614259
[TBL] [Abstract][Full Text] [Related]
5. Dysregulation of SOX17/NRF2 axis confers chemoradiotherapy resistance and emerges as a novel therapeutic target in esophageal squamous cell carcinoma.
Hsieh CH; Kuan WH; Chang WL; Kuo IY; Liu H; Shieh DB; Liu H; Tan B; Wang YC
J Biomed Sci; 2022 Oct; 29(1):90. PubMed ID: 36310172
[TBL] [Abstract][Full Text] [Related]
6. NRF2/HO-1 axis, BIRC5, and TP53 expression in ESCC and its correlation with clinical pathological characteristics and prognosis.
Gao Y; Wan L; Li M; Wang B; Ma Y
Int J Biol Markers; 2023 Dec; 38(3-4):174-184. PubMed ID: 37312528
[TBL] [Abstract][Full Text] [Related]
7. HMGA1 drives chemoresistance in esophageal squamous cell carcinoma by suppressing ferroptosis.
Yang JY; Lei XY; He KY; Guo JR; Liu MJ; Li JQ; Li QT; Jiang ZH; Zhang L; Wu DH; Li YJ; Sun QH; Jian YP; Xu ZX
Cell Death Dis; 2024 Feb; 15(2):158. PubMed ID: 38383528
[TBL] [Abstract][Full Text] [Related]
8. Nrf2 and Keap1 abnormalities in esophageal squamous cell carcinoma and association with the effect of chemoradiotherapy.
Zhang J; Jiao Q; Kong L; Yu J; Fang A; Li M; Yu J
Thorac Cancer; 2018 Jun; 9(6):726-735. PubMed ID: 29675925
[TBL] [Abstract][Full Text] [Related]
9. Repurposed pizotifen malate targeting NRF2 exhibits anti-tumor activity through inducing ferroptosis in esophageal squamous cell carcinoma.
He X; Zhou Y; Chen W; Zhao X; Duan L; Zhou H; Li M; Yu Y; Zhao J; Guo Y; Gu H; Jiang Y; Dong Z; Liu K
Oncogene; 2023 Apr; 42(15):1209-1223. PubMed ID: 36841865
[TBL] [Abstract][Full Text] [Related]
10. Ibuprofen induces ferroptosis of glioblastoma cells via downregulation of nuclear factor erythroid 2-related factor 2 signaling pathway.
Gao X; Guo N; Xu H; Pan T; Lei H; Yan A; Mi Y; Xu L
Anticancer Drugs; 2020 Jan; 31(1):27-34. PubMed ID: 31490283
[TBL] [Abstract][Full Text] [Related]
11. PLK1 regulating chemoradiotherapy sensitivity of esophageal squamous cell carcinoma through pentose phosphate pathway/ferroptosis.
Zhao M; Lu T; Bi G; Hu Z; Liang J; Bian Y; Feng M; Zhan C
Biomed Pharmacother; 2023 Dec; 168():115711. PubMed ID: 37879213
[TBL] [Abstract][Full Text] [Related]
12. The roles of ferroptosis regulatory gene SLC7A11 in renal cell carcinoma: A multi-omics study.
Xu F; Guan Y; Xue L; Zhang P; Li M; Gao M; Chong T
Cancer Med; 2021 Dec; 10(24):9078-9096. PubMed ID: 34761566
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of Nrf2/HO-1 expression and its correlation with occurrence in esophageal squamous cell carcinoma.
Gao Y; Li M; Wang B; Ma Y
Genes Genomics; 2023 Jun; 45(6):723-739. PubMed ID: 37043130
[TBL] [Abstract][Full Text] [Related]
14. SLC7A11, a component of cysteine/glutamate transporter, is a novel biomarker for the diagnosis and prognosis in laryngeal squamous cell carcinoma.
Ma Z; Zhang H; Lian M; Yue C; Dong G; Jin Y; Li R; Wan H; Wang R; Wang Y; Zhai J; Ma H; Feng L; Han J; Liu S; Guo Y; Li J; Liu Y; Fang J; Liu H
Oncol Rep; 2017 Nov; 38(5):3019-3029. PubMed ID: 29048627
[TBL] [Abstract][Full Text] [Related]
15. Nrf2 inhibits ferroptosis and protects against acute lung injury due to intestinal ischemia reperfusion via regulating SLC7A11 and HO-1.
Dong H; Qiang Z; Chai D; Peng J; Xia Y; Hu R; Jiang H
Aging (Albany NY); 2020 Jun; 12(13):12943-12959. PubMed ID: 32601262
[TBL] [Abstract][Full Text] [Related]
16. Nrf2 and its dependent autophagy activation cooperatively counteract ferroptosis to alleviate acute liver injury.
Liu J; Huang C; Liu J; Meng C; Gu Q; Du X; Yan M; Yu Y; Liu F; Xia C
Pharmacol Res; 2023 Jan; 187():106563. PubMed ID: 36410674
[TBL] [Abstract][Full Text] [Related]
17. A novel link between circPDE3B and ferroptosis in esophageal squamous cell carcinoma progression.
Zhou P; Wu Z; Zhang Q; Wang L; Zhang W; Han X
Genomics; 2024 Jan; 116(1):110761. PubMed ID: 38092323
[TBL] [Abstract][Full Text] [Related]
18. The N6-methyladenosine modification enhances ferroptosis resistance through inhibiting SLC7A11 mRNA deadenylation in hepatoblastoma.
Liu L; He J; Sun G; Huang N; Bian Z; Xu C; Zhang Y; Cui Z; Xu W; Sun F; Zhuang C; Man Q; Gu S
Clin Transl Med; 2022 May; 12(5):e778. PubMed ID: 35522946
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of Claudin5 promotes malignant progression and radioresistance through Beclin1-mediated autophagy in esophageal squamous cell carcinoma.
Huang S; Zhang J; Li Y; Xu Y; Jia H; An L; Wang X; Yang Y
J Transl Med; 2023 Jun; 21(1):379. PubMed ID: 37303041
[TBL] [Abstract][Full Text] [Related]
20. Dihydroquercetin suppresses cigarette smoke induced ferroptosis in the pathogenesis of chronic obstructive pulmonary disease by activating Nrf2-mediated pathway.
Liu X; Ma Y; Luo L; Zong D; Li H; Zeng Z; Cui Y; Meng W; Chen Y
Phytomedicine; 2022 Feb; 96():153894. PubMed ID: 34942457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]